Table 1.
Socio-demographic and clinical features of the 30 patients with HCC
| Patients baseline characteristics | |
|---|---|
| Socio-demographical features | |
| Sex-ratio (M:F) | 2.75 |
| Median age, yr (IQRa) | 53.7 (43–64) |
| Low socio-economical standardb n (%) | 5 (16.7) |
| Living in Abidjan n (%) | 18 (60.0) |
| Ethnical origin | |
| Akan-speaking areas n (%) | 11 (36.6) |
| Gur-speaking areas n (%) | 5 16.6) |
| Kru-speaking areas n (%) | 4 (13.3) |
| Mandé-speaking areas n (%) | 7 (23.3) |
| Foreign born (Burkina Faso) n (%) | 3 (10.0) |
| Lifestyle features | |
| History of heavy drinking n (%) | 7 (23.3) |
| Tobacco use n (%) | 3 (10.0) |
| Cassava consumption n (%) | 19 (63.3) |
| Maize flour consumption n (%) | 16 (53.3) |
| Peanut consumption n (%) | 20 (66.7) |
| Risk factors of infection | |
| Dental treatment n (%) | 8 (26.6) |
| Invasive medical practicesc n (%) | 11 (36.6) |
| Ritual scarifications n (%) | 12 (40.0) |
| Sex-transmitted infections n (%) | 3 (10.0) |
| Clinical features | |
| Metabolic disease (Type 2 diabetes, obesity) n (%) | 6 (20.0) |
| Hepatomegaly n (%) | 25 (83.3) |
| Jaundice n (%) | 21 (70.0) |
| Bruises n (%) | 7 (23.3) |
| Portal anastomoses n (%) | 5 (16.6) |
| Liver pain n (%) | 20 (66.7) |
| Ascites n (%) | 21 (70.0) |
| Multi-nodular tumors n (%) | 27 (90.0) |
| ECOG clinical stage**** n (%) | |
| - 1 or 2 | 8 (26.7) |
| - 3 or 4 | 22 (73.3) |
| Biochemistry | |
| Alpha-feotoprotein >400 ng/mL n (%) | 13 (43.3) |
| Hemoglobin (g/dL ± SD) | 10.2 ± 2.0 |
| Prothrombin ratio (% ± SD) | 69.3 ± 20.5 |
| ASAT (UI/mL, mean ± SEM) | 211 ± 45 |
| ALAT (UI/mL, mean ± SEM) | 143 ± 26 |
aIQR = Interquartile range; b6 persons living in <3 rooms-house
c: transfusion, surgery, drug dispensation with non disposable syringes
****ECOG = Eastern Cooperative Oncology Group